Synthesis and anti-mycobacterial activities of triazoloquinolones

European Journal of Medicinal Chemistry

Volumn 46, Issue 1, 2011, Pages 320-326

  Carta, Antonio ^a   Palomba, Michele ^a   Briguglio, Irene ^a   Corona, Paola ^a   Piras, Sandra ^a   Jabes, Daniela ^b   Guglierame, Paola ^b   Molicotti, Paola ^a   Zanetti, Stefania ^a  

^a UNIVERSITY OF SASSARI   (Italy)

^b NeED Pharmaceuticals   (Italy)

Author keywords

Anti mycobacterial activity; Benzotriazolo; M. tuberculosis; Triazoloquinolones

Indexed keywords

3 BENZYL 9 BUTYL 6 OXO 6,9 DIHYDROTRIAZOLO[4,5 H]QUINOLINE 7 CARBOXYLIC ACID; 3 BENZYL 9 ETHYL 6 OXO 6,9 DIHYDROTRIAZOLO[4,5 H]QUINOLINE 7 CARBOXYLIC ACID; 3 BENZYL 9 METHYL 6 OXO 6,9 DIHYDROTRIAZOLO[4,5 H]QUINOLINE 7 CARBOXYLIC ACID; 3 METHYL 9 (2 METHYLALLYL) 6 OXO 6,9 DIHYDROTRIAZOLO[4,5 H]QUINOLINE 7 CARBOXYLIC ACID; 9 (CYCLOBUTYLMETHYL) 3 METHYL 6 OXO 6,9 DIHYDROTRIAZOLO[4,5 H]QUINOLINE 7 CARBOXYLIC ACID; 9 (CYCLOPROPYLMETHYL) 3 METHYL 6 OXO 6,9 DIHYDROTRIAZOLO[4,5 H]QUINOLINE 7 CARBOXYLIC ACID; 9 ALLYL 3 BENZYL 6 OXO 6,9 DIHYDROTRIAZOLO[4,5 H]QUINOLINE 7 CARBOXYLIC ACID; 9 TERT BUTYL 3 METHYL 6 OXO 6,9 DIHYDROTRIAZOLO[4,5 H]QUINOLINE 7 CARBOXYLIC ACID; ANTIMYCOBACTERIAL AGENT; CIPROFLOXACIN; ETHAMBUTOL; ETHYL 3 BENZYL 9 BUTYL 6 OXO 6,9 DIHYDROTRIAZOLO[4,5 H]QUINOLINE 7 CARBOXYLIC ACID; ETHYL 3 BENZYL 9 ETHYL 6 OXO 6,9 DIHYDROTRIAZOLO[4,5 H]QUINOLINE 7 CARBOXYLIC ACID; ETHYL 3 BENZYL 9 METHYL 6 OXO 6,9 DIHYDROTRIAZOLO[4,5 H]QUINOLINE 7 CARBOXYLIC ACID; ETHYL 3 METHYL 9 (2 METHYLALLYL) 6 OXO 6,9 DIHYDROTRIAZOLO[4,5 H]QUINOLINE 7 CARBOXYLIC ACID; ETHYL 9 (CYCLOBUTYLMETHYL) 3 METHYL 6 OXO 6,9 DIHYDROTRIAZOLO[4,5 H]QUINOLINE 7 CARBOXYLIC ACID; ETHYL 9 (CYCLOPROPYLMETHYL) 3 METHYL 6 OXO 6,9 DIHYDROTRIAZOLO[4,5 H]QUINOLINE 7 CARBOXYLIC ACID; ETHYL 9 ALLYL 3 BENZYL 6 OXO 6,9 DIHYDROTRIAZOLO[4,5 H]QUINOLINE 7 CARBOXYLIC ACID; ETHYL 9 TERT BUTYL 3 METHYL 6 OXO 6,9 DIHYDROTRIAZOLO[4,5 H]QUINOLINE 7 CARBOXYLIC ACID; ISONIAZID; METHYL GROUP; QUINOLONE DERIVATIVE; RIFAMPICIN; STREPTOMYCIN; UNCLASSIFIED DRUG;

ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIUM ISOLATE; CONTROLLED STUDY; DRUG SYNTHESIS; HUMAN; HUMAN CELL; MINIMUM INHIBITORY CONCENTRATION; MULTIDRUG RESISTANCE; MYCOBACTERIUM BOVIS; MYCOBACTERIUM SMEGMATIS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; STRUCTURE ACTIVITY RELATION;

ANTI-BACTERIAL AGENTS; CANDIDA; CELL LINE, TUMOR; HUMANS; MICROBIAL SENSITIVITY TESTS; MYCOBACTERIUM; QUINOLONES;

EID: 78650514128     PISSN: 02235234     EISSN: 17683254     Source Type: Journal    
DOI: 10.1016/j.ejmech.2010.11.020     Document Type: Article

References (41)

1. A.R. Katritzky Farmaco, Ed. Sci. 43 1988 1175 1181
2. A.R. Katritzky, S. Rachwal, and G.J. Hitchings Tetrahedron 47 1991 2683 2732
3. A.R. Katritzky, J. Jiang, J.V. Greenhill, and P.J. Steel J. Chem. Soc. Perkin Trans. 1 1992 3055 3060
4. F. Sparatore, and F. Pagani Farmaco, Ed. Sci. 17 1962 414 429
5. F. Sparatore, and F. Pagani Farmaco, Ed. Sci. 20 1965 248 258
6. F. Sparatore, M.I. La Rotonda, G. Paglietti, E. Ramundo, C. Silipo, and A. Vittoria Farmaco, Ed. Sci. 33 1978 901 923
7. F. Sparatore, F. Pagani, G. Caliendo, E. Novellino, C. Silipo, and A. Vittoria Farmaco, Ed. Sci. 43 1988 141 151
8. A. Boido, I. Vazzana, F. Sparatore, B. Cappello, V. Diurno, C. Matera, R. Marrazzo, S. Russo, M.L. Cenicola, and E. Marmo Farmaco 44 1989 257 277
9. M. Loriga, G. Paglietti, F. Sparatore, G. Pinna, and A. Sisini Farmaco 47 1992 439 448
10. G. Paglietti, P. Sanna, A. Carta, F. Sparatore, I. Vazzana, A. Peana, and M. Satta Farmaco 49 1994 693 702
11. I. Vazzana, A. Boido, F. Sparatore, R. Di Carlo, G.M. Raso, and M. Pacilio Farmaco 52 1997 131 139
12. G. Paglietti, and F. Sparatore Farmaco, Ed. Sci. 27 1972 380 396
13. G. Paglietti, and F. Sparatore Ann. Chim. 62 1972 128 143
14. A. Carta, P. Sanna, G. Paglietti, and F. Sparatore Heterocycles 55 2001 1133 1140
15. P. Sanna, A. Carta, G. Paglietti, S. Zanetti, and G. Fadda Farmaco 47 1992 1001 1019
16. P. Sanna, A. Carta, G. Paglietti, A. Bacchi, and G. Pelizzi J. Heterocycl. Chem. 34 1997 97 106
17. A. Carta, P. Sanna, and H. Molinari Heterocycles 45 1997 1391 1395
18. P. Sanna, A. Carta, and G. Paglietti Heterocycles 51 1999 2171 2181
19. A. Carta, P. Sanna, and A. Bacchi Heterocycles 57 2002 1079 1090
20. P. Sanna, A. Carta, and M.E. Rahbar Nikookar Eur. J. Med. Chem. 35 2000 535 543
21. P. Sanna, A. Carta, L. Gherardini, and M.E. Rahbar Nikookar Farmaco 57 2002 79 87
22. A. Carta, P. Sanna, M. Palomba, L. Vargiu, M. La Colla, and R. Loddo Eur. J. Med. Chem. 37 2002 891 900
23. A. Carta, M. Palomba, G. Boatto, B. Busonera, M. Mureddu, and R. Loddo Farmaco 59 2004 637 644
24. K. Fries, H. Guterbock, and C.H. Kuhn Liebigs Ann. Chem. 511 1934 213
25. R.H. Slater J. Chem. Soc. 1932 2196
26. M.G. Ferlin, I. Castagliuolo, and G. Chiarelotto J. Heterocycl. Chem. 39 2002 631 638
27. A. Nuvole, P. Sanna, G. Paglietti, C. Juliano, and P. Cappucinelli Il Farmaco 44 1989 619 632
28. P. Sanna, A. Carta, G. Paglietti, S. Zanetti, and G. Fadda Il Farmaco 47 1992 1001 1019
29. P. Sanna, P.A. Sequi, and G. Paglietti Il Farmaco 50 1995 47 54
30. P. Sanna, A. Carta, and G. Paglietti Heterocycles 53 2000 423 432
31. A. Carta, G. Boatto, G. Paglietti, G. Poni, M.G. Setzu, and P. Caredda Heterocycles 60 2003 833 842
32. A. Carta, and G. Paglietti Arkivoc 5 2004 66 75
33. A. Carta, and G. Paglietti Triazolo[4,5-g]quinolines, imidazo[4,5-g]quinolines, pyrido[2,3-g]quinoxalines and [4,7]phenantrolines. Easy pathway for the syntheses of these N-Tricycles T.S. Kaufman, E.L. Larghi, Modern Approaches to the Synthesis of O- and N-Heterocycles vol. 1 2007 Research Signpost Kerala, India 173 185 (Chapter 7)
34. A. Carta, S. Pricl, S. Piras, M. Fermeglia, P. La Colla, and R. Loddo Eur. J. Med. Chem. 44 2009 5117 5122
35. A. Carta, M. Palomba, G. Paglietti, P. Molicotti, B. Paglietti, S. Cannas, and S. Zanetti Bioorg. Med. Chem. Lett. 17 2007 4791 4794
36. A. Carta, S. Piras, M. Palomba, P. Molicotti, and S. Zanetti Anti-Infect. Agents Med. Chem. 7 2008 134 147
37. R. E. Diehl, R. V. Kendall, US patent 4,086,242 (25 April 1978), Chem. Abstr. 89 (1978) 109512g.
38. National Committee for Clinical Laboratory Standards: Susceptibility Testing of Mycobacteria, Nocardiae, and Other Aerobic Actinomycetes; Approved Standard 2006 - NCCLS document M24-A 2006 NCCLS Wayne, PA
39. National Committee for Clinical Laboratory Standards: Reference Methods for Broth Dilution Antifungal Susceptibility Testing of Yeasts; Approved Standard - Second Edition - 2002 - NCCLS document M27-A2 2006 NCCLS Wayne, PA
40. National Committee for Clinical Laboratory Standards: Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically; Approved Standard - Seventh Edition - 2006 - NCCLS document M7-A7 2006 NCCLS Wayne, PA
41. R. Pauwels, J. Balzarini, M. Baba, R. Snoeck, D. Schols, P. Herdewijn, J. Desmyster, and E. De Clercq J. Virol. Methods 20 1998 309 321